- Home
- NWFL vs ZNTL Comparison
NWFL vs ZNTL Comparison
Compare NWFL & ZNTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWFL
- ZNTL
- Stock Information
- Founded
- NWFL 1870
- ZNTL 2014
- Country
- NWFL United States
- ZNTL United States
- Employees
- NWFL N/A
- ZNTL N/A
- Industry
- NWFL Major Banks
- ZNTL Biotechnology: Pharmaceutical Preparations
- Sector
- NWFL Finance
- ZNTL Health Care
- Exchange
- NWFL Nasdaq
- ZNTL Nasdaq
- Market Cap
- NWFL 249.5M
- ZNTL 273.1M
- IPO Year
- NWFL 1998
- ZNTL 2020
- Fundamental
- Price
- NWFL $29.83
- ZNTL $3.17
- Analyst Decision
- NWFL
- ZNTL Buy
- Analyst Count
- NWFL 0
- ZNTL 8
- Target Price
- NWFL N/A
- ZNTL $10.50
- AVG Volume (30 Days)
- NWFL 9.1K
- ZNTL 1.6M
- Earning Date
- NWFL 10-28-2024
- ZNTL 11-12-2024
- Dividend Yield
- NWFL 4.11%
- ZNTL N/A
- EPS Growth
- NWFL N/A
- ZNTL N/A
- EPS
- NWFL 1.59
- ZNTL N/A
- Revenue
- NWFL $62,305,000.00
- ZNTL $40,560,000.00
- Revenue This Year
- NWFL N/A
- ZNTL N/A
- Revenue Next Year
- NWFL N/A
- ZNTL N/A
- P/E Ratio
- NWFL $18.39
- ZNTL N/A
- Revenue Growth
- NWFL N/A
- ZNTL N/A
- 52 Week Low
- NWFL $23.50
- ZNTL $2.66
- 52 Week High
- NWFL $34.50
- ZNTL $18.07
- Technical
- Relative Strength Index (RSI)
- NWFL 50.30
- ZNTL 42.66
- Support Level
- NWFL $29.23
- ZNTL $2.90
- Resistance Level
- NWFL $31.40
- ZNTL $3.20
- Average True Range (ATR)
- NWFL 1.06
- ZNTL 0.40
- MACD
- NWFL -0.25
- ZNTL -0.08
- Stochastic Oscillator
- NWFL 22.68
- ZNTL 10.39
About NWFL Norwood Financial Corp.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.